Immediate Impact
28 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Hsiu-Chi Ting being referenced
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Hsiu-Chi Ting | 144 | 40 | 24 | 13 | 197 | |
| Olav Mjaavatten | 116 | 38 | 37 | 17 | 276 | |
| Shanshan Lian | 99 | 68 | 60 | 25 | 273 | |
| He Dai | 144 | 36 | 39 | 12 | 267 | |
| Marion R. Wells | 42 | 17 | 9 | 23 | 233 | |
| M Vialli | 44 | 38 | 28 | 23 | 137 | |
| Hashimul Ehsan | 182 | 5 | 50 | 11 | 295 | |
| C. Petzelt | 160 | 6 | 18 | 19 | 264 | |
| Laura H. Gunn | 210 | 39 | 3 | 16 | 292 | |
| Hui Li | 88 | 36 | 6 | 16 | 285 | |
| MR Atkinson | 95 | 14 | 3 | 11 | 281 |
All Works
Login with ORCID to disown or claim papers
Loading papers...